Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (61-70 of 221) with videos related to

Pageof 23
Sort By:
International Journal of Colorectal Disease|August 26, 2010
γ-Catenin is an independent prognostic marker in early stage colorectal cancerJutta Maria Nagel, Lydia Kriegl, David Horst, et al.
Scientific Reports|May 25, 2021
An in-depth analysis of the mitochondrial phylogenetic landscape of CambodiaAnita Kloss-Brandstätter, Monika Summerer, David Horst, et al.
The Journal of Experimental Medicine|May 18, 2018
Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancerEva Marina Schmidt, Sebastian Lamprecht, Cristina Blaj, et al.
Nucleic Acids Research|January 11, 2023
Single-cell gene regulatory network prediction by explainable AIPhilipp Keyl, Philip Bischoff, Gabriel Dernbach, et al.
Cancer Science|March 9, 2021
Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancerGerald B Schulz, Sefer Elezkurtaj, Teresa Börding, et al.
International Journal of Molecular Sciences|February 11, 2023
The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal AdenocarcinomaFlorian N Loch, Carsten Kamphues, Katharina Beyer, et al.
Breast Cancer Research and Treatment|November 16, 2021
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)Paul Jank, Judith Lea Lindner, Annika Lehmann, et al.
BMC Cancer|October 29, 2020
The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
BMC Cancer|November 27, 2020
Correction to: The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
European Radiology|July 7, 2019
Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular densityJulian Marcon, Anno Graser, David Horst, et al.
Pageof 23

Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
International Journal of Colorectal Disease|August 26, 2010
γ-Catenin is an independent prognostic marker in early stage colorectal cancerJutta Maria Nagel, Lydia Kriegl, David Horst, et al.
Scientific Reports|May 25, 2021
An in-depth analysis of the mitochondrial phylogenetic landscape of CambodiaAnita Kloss-Brandstätter, Monika Summerer, David Horst, et al.
The Journal of Experimental Medicine|May 18, 2018
Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancerEva Marina Schmidt, Sebastian Lamprecht, Cristina Blaj, et al.
Nucleic Acids Research|January 11, 2023
Single-cell gene regulatory network prediction by explainable AIPhilipp Keyl, Philip Bischoff, Gabriel Dernbach, et al.
Cancer Science|March 9, 2021
Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancerGerald B Schulz, Sefer Elezkurtaj, Teresa Börding, et al.
International Journal of Molecular Sciences|February 11, 2023
The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal AdenocarcinomaFlorian N Loch, Carsten Kamphues, Katharina Beyer, et al.
Breast Cancer Research and Treatment|November 16, 2021
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)Paul Jank, Judith Lea Lindner, Annika Lehmann, et al.
BMC Cancer|October 29, 2020
The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
BMC Cancer|November 27, 2020
Correction to: The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
European Radiology|July 7, 2019
Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular densityJulian Marcon, Anno Graser, David Horst, et al.
Pageof 23